A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects

NCT04104503 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lu AF11167
DRUG: [14C]-Lu AF11167
DRUG: Lu AF11167 MR tablet prototype formulation selected from part A or 1 mg modified release tablet (reference formulation)

Sponsor

H. Lundbeck A/S